APLS icon

Apellis Pharmaceuticals

183 hedge funds and large institutions have $3.83B invested in Apellis Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 72 increasing their positions, 53 reducing their positions, and 36 closing their positions.

Holders
183
Holders Change
+5
Holders Change %
+2.81%
% of All Funds
2.83%
Holding in Top 10
8
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+60%
% of All Funds
0.12%
New
43
Increased
72
Reduced
53
Closed
36
Calls
$40.8M
Puts
$22.3M
Net Calls
+$18.5M
Net Calls Change
+$19.7M
Name Market Value Shares Shares
Change
Shares
Change %
Wolverine Trading
201
Wolverine Trading
Illinois
-33,143 Closed
RSCM
202
Rock Springs Capital Management
Maryland
-26,458 Closed
Man Group
203
Man Group
United Kingdom
-23,300 Closed
IIM
204
Ipswich Investment Management
Massachusetts
-22,265 Closed
HS
205
HighVista Strategies
Massachusetts
-19,763 Closed
Belvedere Trading
206
Belvedere Trading
Illinois
-13,991 Closed
SCA
207
Sippican Capital Advisors
Massachusetts
-6,513 Closed
Federated Hermes
208
Federated Hermes
Pennsylvania
-3,497 Closed
OSAM
209
O'Shaughnessy Asset Management
Connecticut
-3,006 Closed
MAM
210
Meeder Asset Management
Ohio
-2,628 Closed
QT
211
Quantbot Technologies
New York
-2,100 Closed
PCM
212
Penserra Capital Management
California
-1,990 Closed
Lazard Asset Management
213
Lazard Asset Management
New York
-1,236 Closed
SOW
214
State of Wyoming
Wyoming
-276 Closed
GWS
215
Glassman Wealth Services
Virginia
-36 Closed
EI
216
Ellevest Inc
New York
-30 Closed
QCG
217
Quadrant Capital Group
Ohio
-8 Closed
FHA
218
First Horizon Advisors
Tennessee
-4 Closed
CFGS
219
Concourse Financial Group Securities
Alabama
EP
220
Eversept Partners
New York
ACM
221
Altium Capital Management
New York
Point72 Asset Management
222
Point72 Asset Management
Connecticut
GPP
223
Great Point Partners
Connecticut
ABG
224
Ally Bridge Group
New York
PVI
225
Pura Vida Investments
New York